During the past decade, Duke Clinical Research Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Duke Clinical Research Institute" #1 collaborator was "Innovative Medicines Initiative" with 2 trials as a collaborator and "Janssen Research & Development, LLC" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Duke Clinical Research Institute" are "E. Coli Infection" (1 trials) and "E.Coli Infections" (1 trials). Many other conditions were trialed in "Duke Clinical Research Institute" in a lesser frequency.

The vast majority of trials in "Duke Clinical Research Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Duke Clinical Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Duke Clinical Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Duke Clinical Research Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".